Viemed Healthcare, Inc. (NASDAQ:VMD) President Sells $367,159.70 in Stock

Key Points

• Viemed Healthcare President Michael Moore sold 50,090 shares at an average price of $7.33, resulting in a transaction total of $367,159.70, decreasing his ownership by 28.39%.
• The company's stock was trading down 1.5% and had a market cap of $284.33 million, with a price-to-earnings ratio of 21.56.
• Viemed reported quarterly earnings of $0.08 EPS, meeting estimates, but slightly falling short of revenue expectations with $63.06 million against an estimate of $63.50 million.

Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) President Michael Moore sold 50,090 shares of the stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.33, for a total value of $367,159.70. Following the transaction, the president directly owned 126,343 shares of the company's stock, valued at approximately $926,094.19. This trade represents a 28.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Viemed Healthcare Price Performance

NASDAQ VMD traded up $0.09 on Monday, reaching $6.98. 56,454 shares of the company's stock traded hands, compared to its average volume of 173,744. The stock has a 50-day simple moving average of $6.72 and a 200 day simple moving average of $7.03. Viemed Healthcare, Inc. has a 12 month low of $5.93 and a 12 month high of $9.81. The stock has a market cap of $270.75 million, a PE ratio of 20.51 and a beta of 1.33. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.48 and a quick ratio of 1.37.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.08 EPS for the quarter, hitting analysts' consensus estimates of $0.08. The company had revenue of $63.06 million during the quarter, compared to analyst estimates of $63.50 million. Viemed Healthcare had a return on equity of 10.38% and a net margin of 5.80%.

Hedge Funds Weigh In On Viemed Healthcare

Several large investors have recently modified their holdings of the stock. Martingale Asset Management L P increased its position in shares of Viemed Healthcare by 5.0% during the 1st quarter. Martingale Asset Management L P now owns 36,585 shares of the company's stock valued at $266,000 after purchasing an additional 1,749 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Viemed Healthcare by 18.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,005 shares of the company's stock valued at $105,000 after purchasing an additional 1,997 shares in the last quarter. BCM Advisors LLC raised its position in Viemed Healthcare by 10.6% in the 1st quarter. BCM Advisors LLC now owns 23,520 shares of the company's stock worth $173,000 after purchasing an additional 2,250 shares during the period. Intech Investment Management LLC lifted its position in shares of Viemed Healthcare by 14.4% during the second quarter. Intech Investment Management LLC now owns 18,612 shares of the company's stock worth $129,000 after purchasing an additional 2,349 shares during the last quarter. Finally, LPL Financial LLC lifted its position in shares of Viemed Healthcare by 1.6% during the fourth quarter. LPL Financial LLC now owns 194,690 shares of the company's stock worth $1,561,000 after purchasing an additional 3,000 shares during the last quarter. Hedge funds and other institutional investors own 74.24% of the company's stock.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.